Family Medicine · San Francisco, CA
NPI
1841386141
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1520 Stockton St
San Francisco, CA, 94133
Phone (415) 391-9686
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
2,517 services
Medicare patients, 2024
255
Average age 74
Drug cost, 2024
$1.7M
10,711 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anselm O Lam was code 36415 (venipuncture blood collection), 342 times for 237 patients. In total Anselm O Lam billed 2,517 services in 36 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 342 | 237 | $5.85 | $1,999 |
| 80061 Clinical Chemistry | Office | 278 | 203 | $13.03 | $3,622 |
| 80053 Clinical Chemistry | Office | 249 | 193 | $10.31 | $2,567 |
| 83036 Blood Count | Office | 236 | 173 | $9.44 | $2,228 |
| 85027 Blood Count | Office | 226 | 191 | $6.31 | $1,427 |
| 82043 Clinical Chemistry | Office | 225 | 177 | $5.61 | $1,262 |
| 82570 Clinical Chemistry | Office | 225 | 177 | $5.04 | $1,133 |
| 82306 Clinical Chemistry | Office | 200 | 167 | $28.87 | $5,775 |
| 86480 Immunoassay | Office | 65 | 64 | $44.10 | $2,867 |
| 84443 Clinical Chemistry | Office | 64 | 57 | $15.96 | $1,022 |
| 84550 Clinical Chemistry | Office | 63 | 53 | $4.36 | $275 |
| 85025 Blood Count | Office | 62 | 60 | $7.49 | $464 |
| 81001 Clinical Chemistry | Office | 58 | 54 | $3.06 | $177 |
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 49 | 49 | $17.69 | $867 |
| 80076 Clinical Chemistry | Office | 37 | 36 | $7.79 | $288 |
By year: 2022 $42K for 5,280 services; 2023 $40K for 4,373 services; 2024 $28K for 2,517 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 342 | 237 | $5.85 | $1,999 |
| 80061 Clinical Chemistry | 278 | 203 | $13.03 | $3,622 |
| 80053 Clinical Chemistry | 249 | 193 | $10.31 | $2,567 |
| 83036 Blood Count | 236 | 173 | $9.44 | $2,228 |
| 85027 Blood Count | 226 | 191 | $6.31 | $1,427 |
| 82043 Clinical Chemistry | 225 | 177 | $5.61 | $1,262 |
| 82570 Clinical Chemistry | 225 | 177 | $5.04 | $1,133 |
| 82306 Clinical Chemistry | 200 | 167 | $28.87 | $5,775 |
| 86480 Immunoassay | 65 | 64 | $44.10 | $2,867 |
| 84443 Clinical Chemistry | 64 | 57 | $15.96 | $1,022 |
Medicare prescription drug claims, 2024
In 2024, the drug Anselm O Lam prescribed most often to Medicare patients was Atorvastatin Calcium, with 835 prescriptions and refills. In total Anselm O Lam wrote 10,711 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 835 | 2,430 | 253 | $10K |
| Metoprolol Succinate Generic | 519 | 1,439 | 149 | $11K |
| Amlodipine Besylate Generic | 470 | 1,398 | 133 | $4,906 |
| Losartan Potassium Generic | 455 | 1,314 | 129 | $5,699 |
| Omeprazole Generic | 345 | 653 | 117 | $4,001 |
| Tamsulosin Hcl Generic | 303 | 860 | 99 | $7,276 |
| Metformin Hcl Generic | 295 | 829 | 81 | $3,847 |
| Jardiance Empagliflozin | 295 | 843 | 85 | $417K |
| Hydrochlorothiazide Generic | 270 | 777 | 80 | $925 |
| Simvastatin Generic | 253 | 733 | 70 | $3,068 |
| Glipizide-Metformin Glipizide/Metformin Hcl | 209 | 589 | 58 | $16K |
| Lisinopril Generic | 188 | 546 | 56 | $2,789 |
| Triamcinolone Acetonide Generic | 181 | 187 | 64 | $1,034 |
| Gabapentin Generic | 164 | 324 | 66 | $2,334 |
| Montelukast Sodium Generic | 162 | 377 | 49 | $1,939 |
Brand drugs: 1,745 claims; generic drugs: 8,889 claims; opioid claims: 22.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Anselm O Lam were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.